Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bio Key International (BKYI) Assets (2016 - 2025)

Bio Key International (BKYI) has disclosed Assets for 16 consecutive years, with $10.1 million as the latest value for Q3 2025.

  • Quarterly Assets rose 58.03% to $10.1 million in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $10.1 million through Sep 2025, up 58.03% year-over-year, with the annual reading at $8.6 million for FY2024, 90.73% up from the prior year.
  • Assets hit $10.1 million in Q3 2025 for Bio Key International, down from $10.5 million in the prior quarter.
  • In the past five years, Assets ranged from a high of $21.5 million in Q1 2021 to a low of $4.2 million in Q1 2024.
  • Historically, Assets has averaged $12.0 million across 5 years, with a median of $10.5 million in 2025.
  • Biggest five-year swings in Assets: skyrocketed 611.53% in 2021 and later tumbled 60.41% in 2023.
  • Year by year, Assets stood at $17.8 million in 2021, then crashed by 36.16% to $11.3 million in 2022, then tumbled by 60.18% to $4.5 million in 2023, then surged by 90.73% to $8.6 million in 2024, then grew by 17.38% to $10.1 million in 2025.
  • Business Quant data shows Assets for BKYI at $10.1 million in Q3 2025, $10.5 million in Q2 2025, and $11.2 million in Q1 2025.